Coeptis Therapeutics, Inc. (COEP)
USD 9.75
(2.85%)
USD 9.75
(2.85%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 20.48 Million USD | -40.08% |
| 2022 | 34.19 Million USD | 142.17% |
| 2021 | 14.12 Million USD | 144.32% |
| 2020 | 5.77 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2005 | 308.3 Thousand USD | 2959.49% |
| 2004 | 10.07 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.57 Million USD | -3.53% |
| 2024 Q1 | 2.67 Million USD | -14.23% |
| 2023 Q2 | 3.59 Million USD | -44.25% |
| 2023 Q1 | 6.44 Million USD | 100.33% |
| 2023 FY | 20.48 Million USD | -40.08% |
| 2023 Q4 | 3.11 Million USD | -60.12% |
| 2023 Q3 | 7.81 Million USD | 117.27% |
| 2022 Q4 | 3.21 Million USD | -41.6% |
| 2022 Q3 | 5.51 Million USD | -43.46% |
| 2022 Q2 | 9.74 Million USD | -37.96% |
| 2022 Q1 | 15.71 Million USD | 416.91% |
| 2022 FY | 34.19 Million USD | 142.17% |
| 2021 Q3 | 6.75 Million USD | 161.89% |
| 2021 FY | 14.12 Million USD | 144.32% |
| 2021 Q1 | 1.74 Million USD | 257.09% |
| 2021 Q2 | 2.58 Million USD | 48.3% |
| 2021 Q4 | 3.04 Million USD | -55.02% |
| 2020 FY | 5.77 Million USD | 0.0% |
| 2020 Q4 | 487.36 Thousand USD | 3922.83% |
| 2020 Q3 | 12.11 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2005 FY | 308.3 Thousand USD | 2959.49% |
| 2005 Q1 | 32.00 USD | 0.0% |
| 2005 Q2 | 174.07 Thousand USD | 543896.88% |
| 2005 Q4 | 134.22 Thousand USD | 1643.54% |
| 2005 Q3 | -8696.00 USD | -105.0% |
| 2004 FY | 10.07 Thousand USD | 0.0% |
| 2004 Q4 | - USD | -100.0% |
| 2004 Q3 | 9722.00 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 1.33 Million USD | -1434.328% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -306.381% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 30.667% |
| Nascent Biotech, Inc. | 2.22 Million USD | -818.879% |
| Rebus Holdings, Inc. | 664 Thousand USD | -2985.827% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 45.002% |
| Qrons Inc. | 643.67 Thousand USD | -3083.256% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -5159.671% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 64.328% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -4831.63% |
| Skye Bioscience, Inc. | 13.54 Million USD | -51.244% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 76.39% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -316.638% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -7728.755% |
| SQZ Biotechnologies Company | 85.61 Million USD | 76.069% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -602.614% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -1264.265% |
| Mesoblast Limited | 5.9 Million USD | -247.169% |
| Marizyme, Inc. | 19.23 Million USD | -6.497% |
| Genus plc | 147.7 Million USD | 86.127% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -133.39% |
| Pharming Group N.V. | 225.49 Million USD | 90.913% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -900.139% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -1427.335% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -145.712% |
| ContraFect Corporation | 56.88 Million USD | 63.983% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -364.763% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -1285.62% |
| IMV Inc. | 37.7 Million USD | 45.663% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -634.311% |
| MultiCell Technologies, Inc. | 567.42 USD | -3610962.0% |
| ONE Bio Corp. | 6.44 Million USD | -217.974% |
| Accustem Sciences Inc. | 3.74 Million USD | -446.919% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 76.159% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -3751.758% |
| Q BioMed Inc. | 3.43 Million USD | -496.221% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 17.095% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -679.818% |
| Biomind Labs Inc. | 994.18 Thousand USD | -1960.98% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 79.372% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -1064.411% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -204.999% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -999.025% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 82059.552% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -27.98% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -1016.557% |
| GB Sciences, Inc. | 1.42 Million USD | -1342.433% |
| Alpha Cognition Inc. | 9.7 Million USD | -111.114% |
| HST Global, Inc. | 140.9 Thousand USD | -14441.427% |
| CSL Limited | 3.44 Billion USD | 99.406% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -1721.469% |
| Halberd Corporation | 74.84 Thousand USD | -27277.526% |
| Enzolytics Inc. | 2.17 Million USD | -840.116% |
| Agentix Corp. | 1.37 Million USD | -1393.698% |
| Resverlogix Corp. | 12.71 Million USD | -61.185% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -461.258% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 98.664% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -1862.633% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -751.994% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -1197.358% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -501.763% |
| AVAX Technologies, Inc. | 7.31 Million USD | -180.289% |
| Zenith Capital Corp. | 8.94 Million USD | -129.116% |
| Genscript Biotech Corporation | 825.34 Million USD | 97.517% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -117516.027% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -734.511% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -11846.83% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -966.678% |
| Kadimastem Ltd | 2.41 Million USD | -750.163% |
| Helix BioMedix, Inc. | 1.97 Million USD | -939.023% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -88.551% |
| BioStem Technologies, Inc. | 22.97 Million USD | 10.816% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -11190.128% |
| LadRx Corporation | 3.81 Million USD | -437.54% |
| Cell Source, Inc. | 4.32 Million USD | -373.717% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -2118.697% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -2118.697% |
| NovAccess Global Inc. | 2.46 Million USD | -730.639% |
| Affymax, Inc. | 39.38 Million USD | 47.977% |
| Itoco Inc. | 919.14 Thousand USD | -2129.238% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -383.433% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -1731.089% |
| Mobile Lads Corp. | 554.54 Thousand USD | -3594.894% |
| CytoDyn Inc. | 18.05 Million USD | -13.467% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -81309.226% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -9210.285% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -1343.161% |
| SYBLEU INC | 160.87 Thousand USD | -12636.448% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -1028.099% |
| International Stem Cell Corporation | 5.27 Million USD | -288.729% |
| Bioxytran, Inc. | 3.82 Million USD | -436.364% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -38823.08% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -100622.057% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 43.501% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -1166.371% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -2684.576% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -558.627% |
| Neutra Corp. | 243.82 Thousand USD | -8303.66% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -17.373% |
| PureTech Health plc | 144.59 Million USD | 85.83% |
| IXICO plc | 4.7 Million USD | -335.307% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -132.919% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 82.599% |
| CSL Limited | 3.89 Billion USD | 99.474% |
| Cellectis S.A. | 97.32 Million USD | 78.946% |